Similar articles

• The effect of comorbidities for the prognosis of community-acquired pneumonia: an epidemiologic study using a hospital surveillance in Japan.

  Nguyen MTN, Saito N, Wagatsuma Y. Nguyen MTN, et al. BMC Res Notes. 2019 Dec 19;12(1):817. doi: 10.1186/s13104-019-4848-1. BMC Res Notes. 2019. PMID: 31856910 Free PMC article.
• Intra-hospital mortality for community-acquired pneumonia in mainland Portugal between 2000 and 2009.

  Teixeira-Lopes F, Cysneiros A, Dias A, Durão V, Costa C, Paula F, Serrado M, Nunes B, Diniz A, Froes F. Teixeira-Lopes F, et al. Pulmonology. 2019 Mar-Apr;25(2):66-70. doi: 10.1016/j.pulmoe.2018.06.004. Epub 2018 Jul 17. Pulmonology. 2019. PMID: 30026065
• The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.

  Luna CM, Palma I, Niederman MS, Membriani E, Giovini V, Wiemken TL, Peyrani P, Ramirez J. Luna CM, et al. Ann Am Thorac Soc. 2016 Sep;13(9):1519-26. doi: 10.1513/AnnalsATS.201512-848OC. Ann Am Thorac Soc. 2016. PMID: 27398827
• Epidemiology of mild pneumonia.

  Marrie TJ. Marrie TJ. Semin Respir Infect. 1998 Mar;13(1):3-7. Semin Respir Infect. 1998. PMID: 9543470 Review.
• Paediatric community-acquired pneumonia: current concept in pharmacological control.

  Principi N, Esposito S. Principi N, et al. Expert Opin Pharmacother. 2003 May;4(5):761-77. doi: 10.1517/14656566.4.5.761. Expert Opin Pharmacother. 2003. PMID: 12739999 Review.